WAY-262611

Lieferant: ENZO LIFE SCIENCES

BMLWN1100005 BMLWN1100025
ENZOBMLWN1100005EA 148 EUR
ENZOBMLWN1100005 ENZOBMLWN1100025
WAY-262611
WAY-262611

DKK1 inhibitor


Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.

Formel: C₂₀H₂₂N₄
Molecular Weight: 318,4 g/mol
MDL: MFCD20527803
CAS-Nummer: 1123231-07-1
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=32a97f9c38fdf5d1dce8c9ad484f1b28a567fd4f&vid=dfae0fb9042bd050c6679c4bf429d1d3aef7bd6b&prid=web&clid=SAPDAM

Bestellen

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR